Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.19
PKI's Cash to Debt is ranked lower than
51% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.78 vs. PKI: 0.19 )
PKI' s 10-Year Cash to Debt Range
Min: 0.15   Max: 2.06
Current: 0.19

0.15
2.06
Equity to Asset 0.51
PKI's Equity to Asset is ranked higher than
60% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. PKI: 0.51 )
PKI' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.63
Current: 0.51

0.32
0.63
Interest Coverage 4.36
PKI's Interest Coverage is ranked higher than
52% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. PKI: 4.36 )
PKI' s 10-Year Interest Coverage Range
Min: 2.15   Max: 16.75
Current: 4.36

2.15
16.75
F-Score: 7
Z-Score: 2.91
M-Score: -2.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.04
PKI's Operating margin (%) is ranked higher than
75% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.96 vs. PKI: 10.04 )
PKI' s 10-Year Operating margin (%) Range
Min: 1.62   Max: 10.86
Current: 10.04

1.62
10.86
Net-margin (%) 7.72
PKI's Net-margin (%) is ranked higher than
75% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. PKI: 7.72 )
PKI' s 10-Year Net-margin (%) Range
Min: -10.1   Max: 22.94
Current: 7.72

-10.1
22.94
ROE (%) 8.38
PKI's ROE (%) is ranked higher than
74% of the 279 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. PKI: 8.38 )
PKI' s 10-Year ROE (%) Range
Min: -12.13   Max: 28.01
Current: 8.38

-12.13
28.01
ROA (%) 4.24
PKI's ROA (%) is ranked higher than
73% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. PKI: 4.24 )
PKI' s 10-Year ROA (%) Range
Min: -5.36   Max: 12.18
Current: 4.24

-5.36
12.18
ROC (Joel Greenblatt) (%) 47.60
PKI's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. PKI: 47.60 )
PKI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.69   Max: 78.05
Current: 47.6

3.69
78.05
Revenue Growth (%) 9.70
PKI's Revenue Growth (%) is ranked higher than
80% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. PKI: 9.70 )
PKI' s 10-Year Revenue Growth (%) Range
Min: -12.3   Max: 17.5
Current: 9.7

-12.3
17.5
EBITDA Growth (%) 8.30
PKI's EBITDA Growth (%) is ranked higher than
75% of the 209 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.50 vs. PKI: 8.30 )
PKI' s 10-Year EBITDA Growth (%) Range
Min: -20.4   Max: 35
Current: 8.3

-20.4
35
EPS Growth (%) 8.80
PKI's EPS Growth (%) is ranked higher than
76% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.80 vs. PKI: 8.80 )
PKI' s 10-Year EPS Growth (%) Range
Min: -78.9   Max: 35.2
Current: 8.8

-78.9
35.2
» PKI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

PKI Guru Trades in Q2 2013

Vanguard Health Care Fund 1,441,400 sh (New)
Steven Cohen 209,537 sh (+191.27%)
Ken Fisher 638,685 sh (+104.07%)
Meridian Funds 759,500 sh (+20.08%)
PRIMECAP Management 1,261,700 sh (+5.55%)
Paul Tudor Jones Sold Out
Stanley Druckenmiller Sold Out
Ray Dalio Sold Out
Chuck Royce 4,010,420 sh (-2.69%)
Columbia Wanger 972,000 sh (-37.49%)
Jim Simons 438,000 sh (-56.48%)
» More
Q3 2013

PKI Guru Trades in Q3 2013

PRIMECAP Management 1,553,900 sh (+23.16%)
Ken Fisher 656,810 sh (+2.84%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Chuck Royce 3,592,620 sh (-10.42%)
Steven Cohen 42,321 sh (-79.8%)
Jim Simons 62,200 sh (-85.8%)
» More
Q4 2013

PKI Guru Trades in Q4 2013

Jim Simons 172,600 sh (+177.49%)
PRIMECAP Management 1,733,244 sh (+11.54%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Steven Cohen Sold Out
Chuck Royce 3,577,620 sh (-0.42%)
Ken Fisher 616,535 sh (-6.13%)
» More
Q1 2014

PKI Guru Trades in Q1 2014

Ken Fisher 609,140 sh (-1.2%)
» More
» Details

Insider Trades

Latest Guru Trades with PKI

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
PRIMECAP Management 2013-09-30 Add 23.16%0.01%$32.39 - $38.63 $ 44.3123%1553900
Vanguard Health Care Fund 2013-06-30 New Buy0.17%$30.35 - $34.95 $ 44.3135%1441400
Meridian Funds 2013-06-30 Add 20.08%0.15%$30.35 - $34.95 $ 44.3135%759500
Ray Dalio 2013-06-30 Sold Out 0.02%$30.35 - $34.95 $ 44.3135%0
David Dreman 2013-03-31 Sold Out 0.8%$31.74 - $35.86 $ 44.3129%0
Meridian Funds 2013-03-31 New Buy0.78%$31.74 - $35.86 $ 44.3129%632500
Ray Dalio 2013-03-31 New Buy0.02%$31.74 - $35.86 $ 44.3129%51497
PRIMECAP Management 2012-12-31 Add 28.06%0.01%$27.84 - $32.29 $ 44.3144%1208106
Mario Gabelli 2012-12-31 Sold Out 0.004%$27.84 - $32.29 $ 44.3144%0
PRIMECAP Management 2012-09-30 Add 56.14%0.02%$23.88 - $30.36 $ 44.3164%943359
Joel Greenblatt 2012-06-30 Sold Out 0.09%$24.96 - $27.9 $ 44.3168%0
Joel Greenblatt 2012-03-31 Reduce -41.22%0.06%$20.37 - $27.85 $ 44.3186%37369
PRIMECAP Management 2012-03-31 Add 241.19%0.01%$20.37 - $27.85 $ 44.3186%515906
David Dreman 2011-12-31 Add 251.88%0.49%$17.49 - $21.61 $ 44.31131%1525635
Ray Dalio 2011-12-31 Sold Out 0.06%$17.49 - $21.61 $ 44.31131%0
PRIMECAP Management 2011-12-31 Add 53.51%$17.49 - $21.61 $ 44.31131%151206
David Dreman 2011-09-30 New Buy0.21%$18.84 - $27.55 $ 44.3193%433571
Ray Dalio 2011-09-30 New Buy0.06%$18.84 - $27.55 $ 44.3194%212908
PRIMECAP Management 2011-09-30 New Buy$18.84 - $27.55 $ 44.3193%98500
Joel Greenblatt 2011-06-30 Add 442.85%0.27%$25.77 - $28.32 $ 44.3164%88507
Joel Greenblatt 2011-03-31 New Buy0.13%$24.72 - $28.03 $ 44.3169%16304
Jean-Marie Eveillard 2011-03-31 Sold Out $24.72 - $28.03 $ 44.3169%0
Mario Gabelli 2011-03-31 Reduce -23.15%$24.72 - $28.03 $ 44.3169%24900
George Soros 2011-03-31 Sold Out $24.72 - $28.03 $ 44.3169%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 30.00
PKI's P/E(ttm) is ranked higher than
57% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.30 vs. PKI: 30.00 )
PKI' s 10-Year P/E(ttm) Range
Min: 5.44   Max: 736.05
Current: 30

5.44
736.05
P/B 2.50
PKI's P/B is ranked higher than
70% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. PKI: 2.50 )
PKI' s 10-Year P/B Range
Min: 0.88   Max: 2.58
Current: 2.5

0.88
2.58
P/S 2.30
PKI's P/S is ranked higher than
64% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. PKI: 2.30 )
PKI' s 10-Year P/S Range
Min: 0.72   Max: 2.4
Current: 2.3

0.72
2.4
PFCF 42.00
PKI's PFCF is ranked higher than
50% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. PKI: 42.00 )
PKI' s 10-Year PFCF Range
Min: 7.78   Max: 92.3
Current: 42

7.78
92.3
EV-to-EBIT 26.30
PKI's EV-to-EBIT is ranked lower than
54% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.39 vs. PKI: 26.30 )
PKI' s 10-Year EV-to-EBIT Range
Min: 9.4   Max: 57.5
Current: 26.3

9.4
57.5
PEG 3.30
PKI's PEG is ranked higher than
56% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.25 vs. PKI: 3.30 )
PKI' s 10-Year PEG Range
Min: 1.86   Max: 38.75
Current: 3.3

1.86
38.75
Shiller P/E 34.40
PKI's Shiller P/E is ranked higher than
54% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. PKI: 34.40 )
PKI' s 10-Year Shiller P/E Range
Min: 10.11   Max: 41.14
Current: 34.4

10.11
41.14

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.60
PKI's Dividend Yield is ranked lower than
78% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. PKI: 0.60 )
PKI' s 10-Year Dividend Yield Range
Min: 0.61   Max: 2.43
Current: 0.6

0.61
2.43
Dividend Payout 0.21
PKI's Dividend Payout is ranked higher than
83% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. PKI: 0.21 )
PKI' s 10-Year Dividend Payout Range
Min: 0.09   Max: 4
Current: 0.21

0.09
4
Yield on cost (5-Year) 0.60
PKI's Yield on cost (5-Year) is ranked lower than
75% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. PKI: 0.60 )
PKI' s 10-Year Yield on cost (5-Year) Range
Min: 0.61   Max: 2.43
Current: 0.6

0.61
2.43
Share Buyback Rate 1.30
PKI's Share Buyback Rate is ranked higher than
91% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.50 vs. PKI: 1.30 )
PKI' s 10-Year Share Buyback Rate Range
Min: 6.8   Max: -10.4
Current: 1.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.70
PKI's Price/DCF (Projected) is ranked higher than
59% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. PKI: 1.70 )
PKI' s 10-Year Price/DCF (Projected) Range
Min: 0.54   Max: 43.03
Current: 1.7

0.54
43.03
Price/Median PS Value 1.40
PKI's Price/Median PS Value is ranked higher than
50% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. PKI: 1.40 )
PKI' s 10-Year Price/Median PS Value Range
Min: 0.23   Max: 1.7
Current: 1.4

0.23
1.7
Price/Peter Lynch Fair Value 5.40
PKI's Price/Peter Lynch Fair Value is ranked lower than
60% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. PKI: 5.40 )
PKI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.9   Max: 16.29
Current: 5.4

0.9
16.29
Earnings Yield (Greenblatt) 3.80
PKI's Earnings Yield (Greenblatt) is ranked higher than
50% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. PKI: 3.80 )
PKI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.7   Max: 10.6
Current: 3.8

1.7
10.6
Forward Rate of Return (Yacktman) 7.83
PKI's Forward Rate of Return (Yacktman) is ranked higher than
79% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.47 vs. PKI: 7.83 )
PKI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.5   Max: 17
Current: 7.83

-5.5
17

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:PKN.Germany
Perkinelmer Inc., a Massachusetts corporation was founded in 1947. The Company is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through its advanced technologies, solutions, and services, it addresses critical issues that help to improve the health and safety of people and their environment. The Company reports its business in two segments: Human Health and Environmental Health. Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of critical new therapies. Within the Human Health segment, it serves both the diagnostics and research markets. It provides early detection for genetic disorders from pre-conception to early childhood, as well as digital x-ray flat panel detectors and infectious disease testing for the diagnostics market. In the research market, it provides a broad suite of solutions including reagents, liquid handling and detection technologies that enable researchers to improve the drug discovery process. Human Health segment offers additional products under various brand names, including AlphaLISA, AlphaScreen, AutoDELFIA, Columbus, EnSpire, EnVision, Evolution, FMT, Genoglyphix, Geospizer, inForm, IVIS, JANUS, LabChip, LANCE, LifeCycle, Living Image, Maestro, MultiPROBE, NEN, NTD Labs, Nuance, Oncoglyphix, Opera, Operetta, Packard, Pannoramic, Quantum, ScanArray, Sciclone, SignatureChip, Signature Precision Panel, Specimen Gate, SureFire, TRIO, Twister, VariSpec, Vectra, ViaCord, VICTOR, Volocity, Wizard, XRD amorphous silicon FPDs, and Zephyr. Environmental Health segment provides technologies and applications to facilitate the creation of safer food and consumer products, more secure surroundings and efficient energy resources. Environmental Health segment serves the environmental, industrial and laboratory services markets. For the environmental market, it provides analytical technologies that address the quality of its environment, sustainable energy development, and help ensure safer food and consumer products. Its technologies are used to detect and help reduce the impact products and industrial processes may have on its environment. It provides a variety of solutions that detect the presence of potentially dangerous materials, including lead and phthalates, in toys and other consumer products to help ensure their safety for use or consumption. It provides analytical instrumentation for the industrial market which includes the semiconductor, chemical, petrochemical, lubricant, construction, office equipment and quality assurance industries. All of the Company's businesses market their products and services directly through their own specialized sales forces. The Company's operations are subject to various foreign, federal, state and local environmental and safety laws and regulations.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide